Attached files
| file | filename |
|---|---|
| EX-10.39 - EX-10.39 - Sage Therapeutics, Inc. | sage-ex1039_559.htm |
| 10-K - 10-K - Sage Therapeutics, Inc. | sage-10k_20201231.htm |
| EX-32.1 - EX-32.1 - Sage Therapeutics, Inc. | sage-ex321_10.htm |
| EX-31.2 - EX-31.2 - Sage Therapeutics, Inc. | sage-ex312_6.htm |
| EX-31.1 - EX-31.1 - Sage Therapeutics, Inc. | sage-ex311_9.htm |
| EX-23.1 - EX-23.1 - Sage Therapeutics, Inc. | sage-ex231_7.htm |
| EX-10.42 - EX-10.42 - Sage Therapeutics, Inc. | sage-ex1042_253.htm |
| EX-10.41 - EX-10.41 - Sage Therapeutics, Inc. | sage-ex1041_252.htm |
| EX-10.40 - EX-10.40 - Sage Therapeutics, Inc. | sage-ex1040_251.htm |
| EX-10.38 - EX-10.38 - Sage Therapeutics, Inc. | sage-ex1038_558.htm |
Exhibit 21.1
SUBSIDIARIES
|
|
|
Subsidiary |
|
Jurisdiction of Incorporation |
|
|
|
|
|
|
|
1 |
|
Sage Securities Corporation |
|
Massachusetts |
|
2 |
|
Sage (Bermuda) Ltd. |
|
Bermuda |
|
3 |
|
Sage Therapeutics Limited |
|
England and Wales |
|
4 |
|
Sage Therapeutics GmbH |
|
Switzerland |
|
5 |
|
Sage Therapeutics GmbH |
|
Germany |